NeuronAlgo
~/backtests/na-nas-l-013 backtest

$ cd /evidence  ·  evidence archive

Backtest evidence

Gamma Cancer

code: NA-NAS-L-013 NasdaQ_Oanda H1 2006-01-02 → 2026-06-19
net $5,503 trades 417 win 62.32%
at-a-glance --summaryok

$ stats --glance

headline performance at a glance

net_profit
Total net profit $5,503
gross profit$21,811
gross loss$16,307
win_rate
62.32%WIN
██████░░░░
Win rate
258W / 156L
profit_factor
1.34PF
████░░░░░░
Profit factor
gross P / gross L
cagr
2.22%CAGR
░░░░░░░░░
CAGR
annualized
max_drawdown
-19.19%MAX DD
██░░░░░░░░
Max drawdown
$1,919
equity_curve --renderok

$ plot --equity

cumulative account equity over the test window

Stored snapshot: 834 points; starts at $10,000.00, ends at $15,503.18; observed range $8,080.72–$15,503.18.

x: time · y: equity (USD)● rendered by na-backtest-charts

$ plot --drawdown

underwater equity (peak-to-trough), in account currency — risk per trade is a fixed dollar amount, so a percent axis would shrink every year as the balance grew

x: time · y: drawdown (USD)● rendered by na-backtest-charts
trade_breakdown --analyzepartial

$ trades --breakdown

win/loss split, averages, and streaks

win_loss_split
62.32%win
Wins258
Losses156
Total417
win_vs_loss_size
Avg win$84.54
Avg loss$104.53
Largest win$258.30
Largest loss-$216.00
key_ratios
Profit factor1.34
Win/Loss ratio1.65
Payout ratio0.81
Expectancy$13.20
Avg trade$13.20
Bars in trade7.81
streaks
Max consec wins9
Max consec losses4
Avg consec wins1.00
Avg consec losses1.00
Long vs short breakdown and per-trade distributions are not in the ingested dataset yet.
full_statistics --allok

$ stats --full

complete metric set, grouped by category

$5,503
Net profit
$21,811
Gross profit
$16,307
Gross loss
2.22%
CAGR
2.62
AHPR
$275
Yearly avg profit
$22
Monthly avg profit
$0.74
Daily avg profit
2.75%
Yearly avg return
1.78%
Exposure
417
Trades
$13.20
Avg trade
run.configok

$ cat run.config

parameters used for this run

instrumentNasdaQ_Oanda
timeframeH1
period start2006-01-02
period end2026-06-19
profit in pips103153.1 ticks
strategyview →
Trading financial instruments carries a high level of risk and may not be suitable for all investors. Past performance — including backtested and simulated results — is not indicative of future results. NeuronAlgo provides research and tooling, not financial advice.
nextok

Explore the strategy behind this run

See the full methodology, risk profile, and live track record — or browse every backtest in the library.

Generated from stored backtest metrics · NeuronAlgo research desk

Scroll to Top